GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NutraLife Biosciences Inc (OTCPK:NLBS) » Definitions » Piotroski F-Score
中文

NutraLife Biosciences (NutraLife Biosciences) Piotroski F-Score : 0 (As of Apr. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is NutraLife Biosciences Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

NutraLife Biosciences has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for NutraLife Biosciences's Piotroski F-Score or its related term are showing as below:


NutraLife Biosciences Piotroski F-Score Historical Data

The historical data trend for NutraLife Biosciences's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NutraLife Biosciences Piotroski F-Score Chart

NutraLife Biosciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 2.00 2.00 4.00 2.00

NutraLife Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 3.00 3.00 5.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep22) TTM:Last Year (Sep21) TTM:
Net Income was -0.827 + -1.084 + -0.9 + -1.178 = $-3.99 Mil.
Cash Flow from Operations was 0.472 + -0.453 + -0.248 + -0.44 = $-0.67 Mil.
Revenue was 0.38 + 0.08 + 0.056 + 0.115 = $0.63 Mil.
Gross Profit was 0.013 + -0.043 + 0.051 + 0.095 = $0.12 Mil.
Average Total Assets from the begining of this year (Sep21)
to the end of this year (Sep22) was
(4.522 + 4.851 + 5.589 + 5.205 + 6.033) / 5 = $5.24 Mil.
Total Assets at the begining of this year (Sep21) was $4.52 Mil.
Long-Term Debt & Capital Lease Obligation was $0.35 Mil.
Total Current Assets was $0.87 Mil.
Total Current Liabilities was $4.45 Mil.
Net Income was -0.98 + -2.501 + -1.811 + -0.688 = $-5.98 Mil.

Revenue was 0.299 + 0.136 + 0.039 + 0.071 = $0.55 Mil.
Gross Profit was 0.148 + 0.04 + 0.004 + 0.027 = $0.22 Mil.
Average Total Assets from the begining of last year (Sep20)
to the end of last year (Sep21) was
(4.44 + 4.707 + 4.675 + 4.494 + 4.522) / 5 = $4.5676 Mil.
Total Assets at the begining of last year (Sep20) was $4.44 Mil.
Long-Term Debt & Capital Lease Obligation was $0.64 Mil.
Total Current Assets was $0.79 Mil.
Total Current Liabilities was $4.23 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

NutraLife Biosciences's current Net Income (TTM) was -3.99. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

NutraLife Biosciences's current Cash Flow from Operations (TTM) was -0.67. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep21)
=-3.989/4.522
=-0.8821318

ROA (Last Year)=Net Income/Total Assets (Sep20)
=-5.98/4.44
=-1.34684685

NutraLife Biosciences's return on assets of this year was -0.8821318. NutraLife Biosciences's return on assets of last year was -1.34684685. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

NutraLife Biosciences's current Net Income (TTM) was -3.99. NutraLife Biosciences's current Cash Flow from Operations (TTM) was -0.67. ==> -0.67 > -3.99 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep21 to Sep22
=0.352/5.24
=0.06717557

Gearing (Last Year: Sep21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep20 to Sep21
=0.64/4.5676
=0.14011735

NutraLife Biosciences's gearing of this year was 0.06717557. NutraLife Biosciences's gearing of last year was 0.14011735. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep22)=Total Current Assets/Total Current Liabilities
=0.874/4.451
=0.19636037

Current Ratio (Last Year: Sep21)=Total Current Assets/Total Current Liabilities
=0.788/4.226
=0.18646474

NutraLife Biosciences's current ratio of this year was 0.19636037. NutraLife Biosciences's current ratio of last year was 0.18646474. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

NutraLife Biosciences's number of shares in issue this year was 175.721. NutraLife Biosciences's number of shares in issue last year was 167.747. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.116/0.631
=0.18383518

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.219/0.545
=0.40183486

NutraLife Biosciences's gross margin of this year was 0.18383518. NutraLife Biosciences's gross margin of last year was 0.40183486. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep21)
=0.631/4.522
=0.13954003

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep20)
=0.545/4.44
=0.12274775

NutraLife Biosciences's asset turnover of this year was 0.13954003. NutraLife Biosciences's asset turnover of last year was 0.12274775. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+1+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

NutraLife Biosciences has an F-score of 5 indicating the company's financial situation is typical for a stable company.

NutraLife Biosciences  (OTCPK:NLBS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


NutraLife Biosciences Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of NutraLife Biosciences's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


NutraLife Biosciences (NutraLife Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
6601 Lyons Road, Suite L-6, Coconut Creek, FL, USA, 33073
NutraLife BioSciences Inc is engaged in the development, manufacturing and distribution of nutritional and dietary nutritional supplement products. The company is a branded and private label developer, manufacturer and distributor of a wide range of nutraceutical, wellness, and CBD products. It's private-label ingestible and skincare products include CBD-infused oral sprays, tinctures, pet drops, pain balms, and face creams. Its CBD products are derived from the seeds and mature stalks of the Cannabis Sativa plant which includes all parts and varieties of the cannabis sativa plant also known as hemp, which contain a tetrahydrocannabinol concentration.
Executives
Edgar Ward director, 10 percent owner, officer: President and CEO 5851 HOLMBERG RD., UNIT 2511, PARKLAND FL 33067
Neil Catania 10 percent owner, officer: Vice President 5 FIREPLACE CT., EAST NORTHPORT NY 11731
Lee White 10 percent owner, other: 10% Shareholder 130 S. RD., PAGET D0 PG06